Saffelberg Investments participates in Vio - De Tijd

October 10, 2013 - Saffelberg Investments participates in Vio - De Tijd

PDF Article

Press Release

Gemaco working on international growth - De Tijd

August 10, 2013 - Gemaco working on international growth - De Tijd

PDF Article

Watson Pharmaceuticals acquires Uteron Pharma SA to expand global women's health franchise

Jan. 23, 2013 - Watson Pharmaceuticals (NYSE: WPI) today announced that it has completed the acquisition of Belgium-based Uteron Pharma SA for $150 million in cash up front, and up to $155 million in potential future milestone payments. The acquisition of Uteron expands Watson's Global Brands pipeline of Women's Health products including two potential near term global commercial opportunities in contraception and infertility, and one novel oral contraceptive, projected to launch globally in 2018.Saffelberg Investments was one of Uteron's early investors.

Press Release